ERBB2 and breast neoplasm: Breast tumors can be subtyped by immunohistochemistry (IHC) which investigates the expression of four biomarkers: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2/neu) and a marker of proliferation, Ki67.